Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app keep cancer patients on track with their meds?

NCT ID NCT07073807

Knowledge-focused Sponsor: University of California, Irvine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study is testing a new smartphone app designed to help cancer patients remember to take their oral anticancer medications and report any side effects. The app also helps patients communicate with their care team and find support for financial or social needs. Researchers will enroll 35 English- or Spanish-speaking adults with any type of cancer who are starting or recently started oral anticancer therapy. The goal is to see if the app is easy to use and helps patients stick to their treatment plan.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Aug 2025

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Must speak English or Spanish * Must be 18 years of age or older * Have a diagnosis of any type and stage of cancer * Have a new prescription for an oral anticancer therapy (OAT) initiated within the last 90 days or planned to start within the next 15 days * Be receiving treatment at UCI Chao Family Comprehensive Cancer Center-affiliated oncology clinics * Own a smartphone and be willing to receive study-related text messages. Exclusion Criteria: * Have an Eastern Cooperative Oncology Group (ECOG) performance status greater than 2 * Be medically or cognitively unable to give consent or participate in the study * Be participating in another clinical trial that monitors adherence or symptoms related to the newly prescribed OAT

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Financial Stress Medication Adherence neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Neoplasms

Contacts and locations

Locations

  • Chao Family Comprehensive Cancer Center and Ambulatory Care building

    Irvine, California, 92612, United States

  • UCI Health - Yorba Linda

    Yorba Linda, California, 92886, United States

  • UCI Health Cancer Center - Newport

    Newport Beach, California, 92627, United States

  • UCI Health Chao Family Comprehensive Cancer Center

    Orange, California, 92868, United States

  • UCI Health Pacific Breast Care Center

    Newport Beach, California, 92627, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.